Medical News

RSS

Investing in new hepatitis C therapies may have significant economic impact

While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.

18 May 2015

Information needs of cancer survivors differ depending on the type of cancer

Judging by the nature and topics of their information seeking, cancer patients' information needs appear to differ depending on the type of cancer they have and where they are in their survivorship.

18 May 2015

E-cigarette liquid flavors may alter key cellular functions in lung tissue

Certain flavorings used in electronic cigarette liquid may alter important cellular functions in lung tissue, according to new research presented at the 2015 American Thoracic Society International Conference.

18 May 2015

One-quarter of Americans over age 65 at risk to become elder orphans

With an aging Baby Boomer population and increasing numbers of childless and unmarried seniors, nearly one-quarter of Americans over age 65 are currently or at risk to become "elder orphans," a vulnerable group requiring greater awareness and advocacy efforts, according to new research by a North Shore-LIJ geriatrician and palliative care physician.

18 May 2015

AbbVie extends expiration of exchange offer to acquire common stock of Pharmacyclics

AbbVie Inc. today announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of common stock of Pharmacyclics, Inc. to 5 p.m., New York City time, on May 22, 2015.

18 May 2015

Combined therapy shows promise in cystic fibrosis patients

Treatment with two medications that target the most common genetic cause of cystic fibrosis improves lung function and lowers the rate of pulmonary exacerbations, according to the results from a Phase III international clinical trial published online in the New England Journal of Medicine on May 17, 2015.

17 May 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19.

17 May 2015

Buckeye Health Plan receives Dorland Health Case in Point Award

Buckeye Health Plan announced today that it's been awarded a Dorland Health Case in Point Award for its Pregnancy Specialty Care Management Program. The Case in Point Platinum Awards recognizes successful case management programs that focus on the continuum of care coordination.

17 May 2015

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE Urologic Hydrophilic Coated Guidewire, a device cleared by the FDA for urological use.

17 May 2015

Botulinum toxin A effective for treating bladder disorders

While Botulinum toxin A (BTX-A), known to the public as Botox, is commonly associated with smoothing wrinkles for a more youthful appearance, three studies presented at the 110th Annual Scientific Meeting of the American Urological Association are proving BTX-A to be more than just a cosmetic solution.

17 May 2015

Active surveillance appears to be safer management strategy for prostate cancer patients

Four studies evaluating effectiveness, trends and other considerations for active surveillance in managing prostate cancer will be presented during the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Delaying kidney stone treatment could lead to increased costs, patient morbidity

Delaying treatment of kidney stones could lead to increased costs and patient morbidity, according to a new study presented during the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Study highlights link between poor sleep quality and impact of severe LUTS in some men

Sleep quality may have an impact on the severity of lower urinary tract symptoms, or LUTS, in some men, according to new research presented during the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Quitting smoking can help improve outcomes after major urologic surgery

Quitting smoking can lead to a significant improvement in outcomes after major urologic surgery. These new data and their impact on urologic surgery will be highlighted by study authors during a special press conference at the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

Differences in mechanical, chemical makeup of e-cigarettes can have adverse effects on human health

Study finds botulinum toxin injections in epicardial fat pads reduce AF risk immediately following surgery and after one year of follow-up

AF is the most common arrhythmia complicating cardiac surgery and occurs in approximately 30-40 percent of patients undergoing CABG surgery...

15 May 2015

Medical News

Investing in new hepatitis C therapies may have significant economic impact

Information needs of cancer survivors differ depending on the type of cancer

E-cigarette liquid flavors may alter key cellular functions in lung tissue

One-quarter of Americans over age 65 at risk to become elder orphans

AbbVie extends expiration of exchange offer to acquire common stock of Pharmacyclics

Combined therapy shows promise in cystic fibrosis patients

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Buckeye Health Plan receives Dorland Health Case in Point Award

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Botulinum toxin A effective for treating bladder disorders

Active surveillance appears to be safer management strategy for prostate cancer patients

Delaying kidney stone treatment could lead to increased costs, patient morbidity

Study highlights link between poor sleep quality and impact of severe LUTS in some men

Quitting smoking can help improve outcomes after major urologic surgery

Differences in mechanical, chemical makeup of e-cigarettes can have adverse effects on human health

Noninvasive findings reduce catheterisation need in suspected PAH

Early intensive epoprostenol yields best haemodynamic outcomes in PAH

Meta-analysis supports ambrisentan efficacy

New study shows safe levels of exercise differ for men and women with Atrial Firbrillation

Study finds botulinum toxin injections in epicardial fat pads reduce AF risk immediately following surgery and after one year of follow-up

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News